Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.
about
Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian WomenHuman immunodeficiency virus vaccinesChimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Human papillomavirus vaccination in HIV-infected women: need for increased coverage.Prophylactic HPV vaccination: past, present, and future.Developments in L2-based human papillomavirus (HPV) vaccines.Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies.A novel candidate MS2 phage VLP vaccine displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection.A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada
P2860
Q33859491-D090709C-F7D8-47D2-AF1D-88F0A760AF7FQ35674731-2F52F8A5-23A6-4400-815D-76B036A8A842Q36240497-61F4CE23-C81F-4926-8111-AB5A8856DCF4Q36780952-C9C52242-43DD-4BA8-B988-551F62FD36C5Q38597567-A53E3E30-C350-476E-AAD9-3D6F609248FBQ39021001-5CB6DBE5-EF37-4D86-B755-5FC398E155E8Q40064084-15B63E12-A198-45CA-9CDC-6BD3773F76E3Q41931899-3BF0E3E7-A701-43C0-85A4-CA7756F70D61Q45326416-CEB9DA20-8C9E-4BF1-8877-89E594713E59Q49664919-E31390E2-A569-412A-9879-07D3997D3B93Q55215825-CD1DB15D-04AB-44E3-A16D-97312DE2A060Q57171102-FC8F180B-EAB0-4B29-9199-CE4F263FF5DF
P2860
Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Comparison of the immunogenici ...... HPV-45 in HIV-infected adults.
@en
type
label
Comparison of the immunogenici ...... HPV-45 in HIV-infected adults.
@en
prefLabel
Comparison of the immunogenici ...... HPV-45 in HIV-infected adults.
@en
P2093
P2860
P50
P356
P1476
Comparison of the immunogenici ...... HPV-45 in HIV-infected adults.
@en
P2093
Martin Müller
Peter Sehr
P2860
P304
P356
10.4161/HV.27925
P577
2014-02-19T00:00:00Z